Trial Profile
A study of Anakinra for first-line steroid free treatment in Systemic Onset Juvenile Idiopathic Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2018
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism